FDA Inspection 908387 — ATSF NE Office

ATSF NE Office — FEI 3005463425

The FDA completed an inspection of ATSF NE Office on December 18, 2014 in Kimberly, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 18, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Kimberly, WI (United States)